View original post here: MedMira Reports First Quarter Results FY2021
View original post here: MedMira Reports First Quarter Results FY2021
Go here to see the original: FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2
See more here: Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance,...
Read more: Ocugen and Bharat Biotech to Co-Develop COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market
Read the original post: Salarius Pharmaceuticals to Participate in Biotech Showcase Digital and BIO @ JPM During "J.P. Morgan Week 2021"
More here: Resverlogix Announces Apabetalone Treatment Prior to SARS-CoV-2 (COVID-19) Exposure Significantly Reduces Viral Infection – Confirms Plans for...
Originally posted here: Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström...
Read more: Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
Excerpt from: Novus Therapeutics Announces Results of Special Meeting of Stockholders
See original here: Vaxil Retains Investor Engagement and Marketing Firm
Recent Comments